SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016359
Filing Date
2021-11-29
Accepted
2021-11-29 16:01:25
Documents
15
Period of Report
2021-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20211122x8k.htm   iXBRL 8-K 41458
2 EX-10.1 ampe-20211122xex10d1.htm EX-10.1 178223
3 EX-99.1 ampe-20211122xex99d1.htm EX-99.1 13159
4 GRAPHIC ampe-20211122xex99d1001.jpg GRAPHIC 3430
  Complete submission text file 0001558370-21-016359.txt   403178

Data Files

Seq Description Document Type Size
5 EX-101.SCH ampe-20211122.xsd EX-101.SCH 3220
6 EX-101.LAB ampe-20211122_lab.xml EX-101.LAB 15501
7 EX-101.PRE ampe-20211122_pre.xml EX-101.PRE 10516
8 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20211122x8k_htm.xml XML 4728
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 211456125
SIC: 2834 Pharmaceutical Preparations